Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
US FDA grants Fasenra Orphan Drug Designation for hypereosinophilic syndrome
-
US FDA grants Breakthrough Therapy Designation for potential next-generation RSV medicine MEDI8897
-
EMA grants PRIME eligibility for potential next-generation RSV medicine MEDI8897
-
Forxiga receives positive EU CHMP opinion for the treatment of adults with type-1 diabetes
-
Linzess (linaclotide) approved in China for the treatment of irritable bowel syndrome with constipation
-
AstraZeneca announces organisational changes
-
Phase III OLYMPUS and ROCKIES trials for roxadustat met their primary endpoints in chronic kidney disease patients with anaemia
-
Bevespi Aerosphere approved in the EU for chronic obstructive pulmonary disease
-
Lynparza meets primary endpoint in Phase III SOLO-3 trial for the treatment of relapsed BRCA-mutated advanced ovarian cancer
-
Lynparza approved by US FDA for 1st-line maintenance therapy in BRCA-mutated advanced ovarian cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
